UnitedHealth Group Receives “Overweight” Rating from Morgan Stanley (UNH)
UnitedHealth Group (NYSE:UNH)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Morgan Stanley in a research note issued to investors on Wednesday, American Banking and Market News reports.
The analysts wrote, “Reform leads to increased seasonality in 2014. We have updated our model to reflect reform-related costs in 1H14 including the Medicaid industry fee and Medicare funding pressure. As a result, we now expect UNH will achieve roughly 40% of its earnings in 1H14 and 60% of its earnings in 2H14. We now model FY14 EPS of $5.59 vs $5.60 previously, after adjusting for 4Q13 results. Additionally, we have maintained our FY15 EPS of $6.12, which represents 9% Y/Y EPS growth. Despite near-term headwinds, we believe UNH’s long-term earnings power remains intact.”
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Wednesday, January 15th. The company reported $1.41 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.40 by $0.01. The company had revenue of $31.10 billion for the quarter, compared to the consensus estimate of $31.06 billion. During the same quarter last year, the company posted $1.20 earnings per share. UnitedHealth Group’s revenue was up 8.2% compared to the same quarter last year.
A number of other analysts have also recently weighed in on UNH. Analysts at TheStreet reiterated a “buy” rating on shares of UnitedHealth Group in a research note to investors on Tuesday. Separately, analysts at Monness Crespi & Hardt downgraded shares of UnitedHealth Group from a “neutral” rating to a “sell” rating in a research note to investors on Tuesday. They now have a $59.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of UnitedHealth Group in a research note to investors on Friday, January 17th. They now have a $76.00 price target on the stock. One analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have given a buy rating and two have assigned a strong buy rating to the company. UnitedHealth Group has an average rating of “Buy” and an average target price of $78.16.
UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.